Literature DB >> 17590186

Benefits of breastfeeding in cystic fibrosis: a single-centre follow-up survey.

Carla Colombo1, Diana Costantini, Laura Zazzeron, Nadia Faelli, Maria Chiara Russo, Diana Ghisleni, Italo Gatelli, Marcello Giovannini, Enrica Riva, Rolf Zetterström, Carlo Agostoni.   

Abstract

AIM: To study the effect of breastfeeding (BF) on growth, lung function and number of infections during the first 3 years of life in children with cystic fibrosis (CF).
MATERIAL AND METHODS: One hundred forty-six CF patients, 5-18 years old, were recruited at their annual care visit. Information about infant feeding, psychosocial and socioeconomic conditions and smoking exposure was obtained by interviews. Anthropometric parameters at 1 year of age and the number of infections and hospitalisations during the first 3 years of life were obtained from clinical charts. Anthropometrics and pulmonary function parameters were obtained at enrollment.
RESULTS: In CF patients, particularly those with pancreatic insufficiency, the prevalence of BF was lower than the general Italian population. After multivariate analysis patients with prolonged BF showed higher values of CED expiratory volume in 1 sec (FEV-1) (p = 0.001) and a lower number of infections during the first 3 years of life (p = 0.098).
CONCLUSION: Prolonged BF is beneficial in children with CF and may protect them against decline of pulmonary function. Particular attention should be paid to promote BF in infants with CF.

Entities:  

Mesh:

Year:  2007        PMID: 17590186     DOI: 10.1111/j.1651-2227.2007.00397.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

Authors:  Sarah A Jadin; Grace S Wu; Zhumin Zhang; Suzanne M Shoff; Benjamin M Tippets; Philip M Farrell; Tami Miller; Michael J Rock; Hara Levy; HuiChuan J Lai
Journal:  Am J Clin Nutr       Date:  2011-03-23       Impact factor: 7.045

2.  Task-oriented and bottle feeding adversely affect the quality of mother-infant interactions after abnormal newborn screens.

Authors:  Audrey Tluczek; Roseanne Clark; Anne Chevalier McKechnie; Kate Murphy Orland; Roger L Brown
Journal:  J Dev Behav Pediatr       Date:  2010-06       Impact factor: 2.225

3.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

Review 4.  Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies.

Authors:  Daina Kalnins; Michael Wilschanski
Journal:  Drug Des Devel Ther       Date:  2012-06-20       Impact factor: 4.162

5.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

6.  [Breastfeeding and the anthropometric profile of children with sickle cell anemia receiving follow-up in a newborn screening reference service].

Authors:  Zeni Drubi Nogueira; Ney Boa-Sorte; Maria Efigênia de Queiroz Leite; Márcia Miyuki Kiya; Tatiana Amorim; Silvana Fahel da Fonseca
Journal:  Rev Paul Pediatr       Date:  2015-02-03

Review 7.  Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population.

Authors:  Giulio Pulvirenti; Vincenzo Sortino; Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Alessandro Giallongo; Salvatore Leonardi
Journal:  Ital J Pediatr       Date:  2022-09-11       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.